Green Mountain Coffee Roasters Inc. has stripped founder Robert P. Stiller of his position as chairman after he sold shares to meet a margin call at a time when the company’s trading policies prohibited such sales.
Employers added fewer workers than predicted in April, but the jobless rate unexpectedly fell as workers left the labor force. The participation rate, which indicates the share of working-age people in the labor force, fell to it lowest mark since 1981.
Duke Energy Corp. said first-quarter profit fell 42 percent after a regulatory settlement in Indiana increased costs and mild weather reduced heating demand.
Authorities have arrested two Cuban brothers in the 2010 theft of about $80 million in Eli Lilly and Co. prescription drugs from a Connecticut warehouse, a robbery described as one of the biggest pharmaceutical heists in history, the U.S. attorney’s office said Thursday.
More than 20 compounds that Eli Lilly and Co., Pfizer Inc. and AstraZeneca Plc failed to turn into drugs will be tested by U.S.-sponsored scientists in a $20 million program to see if they’ll work against ailments they weren’t aimed at previously.
The market for testosterone-replacement treatments is growing, but health experts say overuse of the drugs can be dangerous.
Grover Norquist, the anti-tax activist who leads Americans for Tax Reform, said he is set to make an announcement Wednesday with Indiana State Treasurer Richard Mourdock, who is opposing six-term Senator Richard Lugar in the state’s May 8 Republican primary.
Super-PACs are playing a heavy role in this year’s election campaigns, including the race between Indiana Sen. Richard Lugar and challenger Richard Mourdock in the Republican primary.
Indianapolis-based WellPoint Inc. sees a $100 billion market in the states it serves to provide managed care for poor, elderly patients in the Medicare and Medicaid programs.
For-profit U.S. colleges, including Carmel-based ITT Educational Services Inc., would be barred from spending federal taxpayer money on advertising, marketing and recruiting under a Senate bill targeting the education-based businesses.
Eli Lilly and Co., facing generic competition to two of its top drugs, needs to rely on new medicines rather than cost-cutting to overcome the revenue loss, CEO John Lechleiter said Thursday in Boston at the annual meeting of the Pharmaceutical Research and Manufacturers of America.
U.S. corn stockpiles are poised to be the smallest in 16 years by August and soybean reserves will be lower than the government expected, potentially accelerating food-price inflation in an election year.
Waning demand for gasoline is putting the United States on course to miss a target for ethanol use for the first time, signaling no let-up in the slide in prices.
Hungary is being sued for political interference in awarding radio licenses, renewing doubts over press freedoms in the nation as the government tries to convince the European Union that it respects media independence.
Express Scripts Inc.’s $29.1 billion bid for rival drug benefit manager Medco Health Solutions Inc. won unconditional approval from U.S. antitrust regulators, clearing the way to create the biggest manager of prescription-drug benefits for corporate and government clients.
More than $3.6 trillion has been restored to U.S. equity values since October amid better-than-estimated earnings and economic data. Indianapolis-based WellPoint Inc. surged 11 percent this week, as the Supreme Court debated the health care law.
Simon Property Group Inc.’s cutting-edge experience as the biggest U.S. mall owner will help Klepierre SA boost rental income at its shopping centers, the French company’s CEO says.
McDonald’s Corp. said Chief Operating Officer Don Thompson, who grew up in Indianapolis and graduated from Purdue University, will take over as CEO, becoming the first black chief of the world’s largest restaurant chain.
Trucking companies, including Indianapolis-based Celadon Group Inc., are struggling to find qualified drivers even as the U.S. unemployment rate remains at the highest level in almost 30 years.
Indianapolis-based Eli Lilly and Co. will introduce “over a dozen” new products in China in the next five years, focusing on “unmet needs” such as cancer and diabetes, CEO John Lechleiter said this week.
